切换至 "中华医学电子期刊资源库"
高级检索
中华肝脏外科手术学电子杂志

中华肝脏外科手术学电子杂志 ›› 2026, Vol. 15 ›› Issue (04) : 529 -536. doi: 10.3877/cma.j.issn.2095-3232.2026.04.005

专家论坛

脾脏肿瘤诊疗策略
牛海鹏1, 王石2,†()   
  1. 1　010010　呼和浩特，内蒙古医科大学研究生院
    2　010010　呼和浩特，内蒙古医科大学内蒙古自治区人民医院肝胆胰脾外科
  • 收稿日期:2025-12-12 出版日期:2026-08-10
  • 通信作者: 王石
  • 基金资助:
    内蒙古自治区自然科学基金项目(2019MS08081，2023MS08016); 内蒙古自治区卫生健康科技计划项目(202201009); 内蒙古医科大学联合项目(YKD2023LH080)

Diagnosis and treatment strategy for splenic tumors

Haipeng Niu1, Shi Wang2,†()   

  1. 1 Graduate School of Inner Mongolia Medical University, Hohhot 010010, China
    2 Department of Hepatobiliary, Pancreatic and Spleen Surgery, Inner Mongolia People's Hospital, Inner Mongolia Medical University, Hohhot 010010, China
  • Received:2025-12-12 Published:2026-08-10
  • Corresponding author: Shi Wang
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

牛海鹏, 王石. 脾脏肿瘤诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(04): 529-536.

Haipeng Niu, Shi Wang. Diagnosis and treatment strategy for splenic tumors[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(04): 529-536.

脾脏肿瘤临床上罕见，包括脾脏良性肿瘤、恶性肿瘤、交界性肿瘤。脾脏肿瘤的临床表现缺乏特异性，鉴别难度大。脾脏肿瘤腹腔镜微创手术行全脾脏切除或部分脾脏切除可以获得较好的预后。脾脏肿瘤虽罕见但不可小觑，对血液学、肿瘤学和普通外科的诊断和管理构成挑战。要不断地加深对脾脏肿瘤的认识，做到早发现、早诊断、早治疗。同时通过细化脾脏肿瘤分级和分期，以达到最小的脾脏损伤，换取最大的脾脏功能保留，减少并发症的发生。本文对脾脏肿瘤的临床表现、相关恶性肿瘤和分级诊疗进行深入综述，依据相关指南及医师经验，分门别类地阐述脾脏肿瘤的诊疗策略。

关键词: 脾脏肿瘤, 诊断, 脾切除术, 微创手术, 消融技术

Splenic tumors are rarely encountered in clinical settings, including benign tumors, malignant tumors and borderline tumors of the spleen. It is challenging to make a differential diagnosis due to non-specific clinical manifestations. Minimally invasive laparoscopic total or partial splenectomy for splenic tumors can achieve favorable prognosis. Splenic tumor is rare but unneglectable, which poses a challenge to the diagnosis and management of hematology, oncology and general surgery. It is necessary to continuously deepen the understanding of splenic tumors, thereby achieving early detection, diagnosis and treatment. Meantime, the classification and staging of splenic tumors should be refined to minimize spleen injury, maximize the preservation of spleen function and reduce the incidence of complications. In this article, clinical manifestations, related malignant tumors and hierarchical diagnosis and treatment of splenic tumors were explicitly reviewed. The diagnosis and treatment strategies of splenic tumors were sorted out according to relevant guidelines and clinical experience.

Key words: Splenic tumors, Diagnosis, Splenectomy, Minimally invasive surgery, Ablation technology
[1]
Damouny M, Mansour S, Khuri S. Primary angiosarcoma of the spleen: an aggressive neoplasm[J]. World J Oncol, 2022, 13(6): 337-342. DOI: 10.14740/wjon1542.
[2]
Huettl F, Lang H. Surgery for primary splenic tumors and metastases of the spleen[J]. Chirurgie (Heidelb), 2023, 94(12): 994-999. DOI: 10.1007/s00104-023-01978-8.
[3]
Huang Z, Sun K, Luo Z, et al. Spleen-targeted delivery systems and strategies for spleen-related diseases[J]. J Control Release, 2024, 370: 773-797. DOI: 10.1016/j.jconrel.2024.05.007.
[4]
Habermalz B, Sauerland S, Decker G, et al. Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES)[J]. Surg Endosc, 2008, 22(4): 821-848. DOI: 10.1007/s00464-007-9735-5.
[5]
杨伟光, 孙备. 脾脏肿瘤的诊治进展[J]. 肝胆外科杂志, 2019, 27(6): 401-404.
[6]
黄权钰, 刘天祥. 原发性脾脏肿瘤的诊断与治疗[J]. 甘肃科技, 2022, 38(12): 109-111, 119.
[7]
Bert T, Tebbe J, Görg C. What should be done with echoic splenic tumors incidentally found by ultrasound?[J]. Z Gastroenterol, 2010, 48(4): 465-471. DOI: 10.1055/s-0028-1109784.
[8]
Krähling H, Seidensticker M, Heindel WL, et al. Diagnostic approach to splenic lesions[J]. Rofo, 2024, 196(6): 573-581. DOI: 10.1055/a-2193-2292.
[9]
Iacobellis F, Schillirò ML, Di Serafino M, et al. Multimodality ultrasound assessment of the spleen: Normal appearances and emergency abnormalities[J]. J Clin Ultrasound, 2023, 51(3): 543-559. DOI: 10.1002/jcu.23414.
[10]
Valizadeh P, Jannatdoust P, Tahamtan M, et al. Differentiating malignant from benign splenic lesions: a meta-analysis and pictorial review of imaging features[J]. Abdom Radiol, 2024, 49(8): 2833-2857. DOI: 10.1007/s00261-024-04447-w.
[11]
Gourtsoyianni S, Laniado M, Ros-Mendoza L, et al. The spectrum of solitary benign splenic lesions—imaging clues for a noninvasive diagnosis[J]. Diagnostics, 2023, 13(12): 2120. DOI: 10.3390/diagnostics13122120.
[12]
Chen NX, Wang ML, Wang HX, et al. Sclerosing angiomatoid nodular transformation of the spleen: multimodality imaging features and literature review[J]. BMC Med Imag, 2023, 23(1): 50. DOI: 10.1186/s12880-023-01008-3.
[13]
Papathanasiou N. PET/CT: clinical role in lymphomas[J]. Hell J Nucl Med, 2023, 26 Suppl: 36-37.
[14]
Barat M, Hoeffel C, Aissaoui M, et al. Focal splenic lesions: Imaging spectrum of diseases on CT, MRI and PET/CT[J]. Diagn Interv Imag, 2021, 102(9): 501-513. DOI: 10.1016/j.diii.2021.03.006.
[15]
Yi SL, Buicko Lopez JL. Splenectomy[M]. Treasure Island (FL): StatPearls Publishing, 2025. Copyright © 2025, StatPearls Publishing LLC. 2025.
[16]
刘桂杰, 李学华, 孙会东, 等. 原发性脾脏肿瘤的临床特点及外科治疗[J]. 临床医学工程, 2013, 20(9): 1119-1120. DOI: 10.3969/j.issn.1674-4659.2013.09.1119.
[17]
Xing D, Li P, Yang Y, et al. Retrospective assessment of the clinical efficacy of laparoscopic partial splenectomy[J]. Exp Ther Med, 2023, 25(5): 210. DOI: 10.3892/etm.2023.11909.
[18]
Zeng S, Wang W, Chen W, et al. Clinical comparative study of laparoscopic partial splenectomy and open partial splenectomy[J]. Wideochir Inne Tech Maloinwazyjne, 2024, 19(2): 211-222. DOI: 10.5114/wiitm.2024.139988.
[19]
Xue HM, Chen P, Zhu XJ, et al. Robot-assisted partial splenectomy for benign splenic tumors: Four case reports[J]. World J Clin Oncol, 2024, 15(10): 1366-1375. DOI: 10.5306/wjco.v15.i10.1366.
[20]
Glusman ZA, Webb JJ. Use of point-of-care ultrasound to diagnose a ruptured splenic hemangioma[J]. Cureus, 2024, 16(7): e63698. DOI: 10.7759/cureus.63698.
[21]
Gundogan E, Sansal M, Gunes O, et al. The incidence of splenic hemangioma and its rupture risk[J]. Ann Med Res, 2018, 25(4): 368. DOI: 10.5455/annalsmedres.2018.04.058.
[22]
Sangiorgio VFI, Arber DA. Vascular neoplasms and non-neoplastic vascular lesions of the spleen[J]. Semin Diagn Pathol, 2021, 38(2): 154-158. DOI: 10.1053/j.semdp.2020.07.001.
[23]
Vural B, Dogan IS, Turhan B, et al. Sclerosing angiomatoid nodular transformation of the spleen: multimodality imaging features[J]. Cureus, 2025: e83488. DOI: 10.7759/cureus.83488.
[24]
Kim JY, Lee HJ, Jung EY, et al. Splenic sclerosing angiomatoid nodular transformation in an 8-year-old child[J]. J Korean Soc Radiol, 2025, 86(1): 191. DOI: 10.3348/jksr.2024.0017.
[25]
Siderakis M, Dodoura S, Gkeneralis G, et al. Organ-preserving embolization of a giant splenic hemangioma in an adult[J]. CVIR Endovasc, 2024, 7(1): 79. DOI: 10.1186/s42155-024-00491-1.
[26]
Kutok JL, Fletcher CDM. Splenic vascular tumors[J]. Semin Diagn Pathol, 2003, 20(2): 128-139. DOI: 10.1016/s0740-2570(03)00011-x.
[27]
Tan M, Low HM, Shelat V, et al. Imaging patterns in non-traumatic spleen lesions in adults: a review[J]. Jpn J Radiol, 2022, 40(7): 664-677. DOI: 10.1007/s11604-022-01250-9.
[28]
Lin JL, Lin C, Wang HL, et al. Splenic artery embolization and splenectomy for spontaneous rupture of splenic hemangioma and its imaging features[J]. Front Cardiovasc Med, 2022, 9: 925711. DOI: 10.3389/fcvm.2022.925711.
[29]
齐峰, 戴朝六. 脾血管瘤的诊断及治疗进展[J/OL]. 中华普外科手术学杂志(电子版), 2021, 15(01): 114-116. DOI: 10.3877/cma.j.issn.1674-3946.2021.01.033.
[30]
魏猛, 朱化刚, 张志功. 脾血管瘤的手术指征探讨及外科治疗现况[J]. 肝胆外科杂志, 2019, 27(1): 77-79.
[31]
Obeidat KA, Afaneh MW, Al-Domaidat HM, et al. Splenic hamartoma: a case report and literature review[J]. Am J Case Rep, 2022, 23: e937195. DOI: 10.12659/ajcr.937195.
[32]
Yazici P, Aydin U, Ersin S, et al. Hamartoma-a rare benign tumor of the spleen: a report of four cases[J]. Eurasian J Med, 2008, 40(1): 48-51.
[33]
Carlomagno N, Duraturo F, Candida M, et al. Multiple splenic hamartomas and familial adenomatous polyposis: a case report and review of the literature[J]. J Med Case Rep, 2015, 9(1): 154. DOI: 10.1186/s13256-015-0627-3.
[34]
Milickovic M, Rasic P, Cvejic S, et al. Splenic hamartomas in children[J]. World J Clin Cases, 2024, 12(11): 1909-1917. DOI: 10.12998/wjcc.v12.i11.1909.
[35]
Martel M, Cheuk W, Lombardi L, et al. Sclerosing angiomatoid nodular transformation (SANT): report of 25 cases of a distinctive benign splenic lesion[J]. Am J Surg Pathol, 2004, 28(10): 1268-1279. DOI: 10.1097/01.pas.0000138004.54274.d3.
[36]
张佳琪, 王慧, 李海宁, 等. 脾脏硬化性血管瘤样结节性转化的临床特征及影像表现[J]. 现代肿瘤医学, 2024, 32(14): 2615-2619. DOI: 10.3969/j.issn.1672-4992.2024.14.021.
[37]
向雪莲, 刘畅, 张建军. 脾脏硬化性血管瘤样结节性转化的临床特征和CT与MRI影像学表现[J]. 浙江临床医学, 2025, 27(2): 262-265.
[38]
Yamasaki S, Nishino H, Anazawa T, et al. Sclerosing angiomatoid nodular transformation of the laparoscopically resected spleen: case reports and review of the literature[J]. Surg Case Rep, 2025, 11(1): 24-0057. DOI: 10.70352/scrj.cr.24-0057.
[39]
Ong BS, Thomas R. Sclerosing angiomatoid nodular transformation (SANT): a rare splenic tumor and unusual cause of Anemia[J]. Am J Case Rep, 2021, 22: e933598. DOI: 10.12659/ajcr.933598.
[40]
Maya Senosiain I, Sánchez Acedo P, Mercado Gutiérrez MR, et al. Sclerosing angiomatoid nodular transformation (SANT) of the spleen: review of the literature[J]. Rev Esp Enferm Dig, 2023, 115(12): 720-721. DOI: 10.17235/reed.2023.9520/2023.
[41]
Jin Y, Hu H, Regmi P, et al. Treatment options for sclerosing angiomatoid nodular transformation of spleen[J]. HPB (Oxford), 2020, 22(11): 1577-1582. DOI: 10.1016/j.hpb.2020.01.014.
[42]
何晓娜, 王斌儒, 张小鹏, 等. 脾包虫囊肿突破脾表面引起胃穿孔1例[J]. 包头医学院学报, 2018, 34(8): 115, 118. DOI: 10.16833/j.cnki.jbmc.2018.08.047.
[43]
Jha R, Maharjan N, Prasad R, et al. Recurrent primary isolated hydatid cyst of spleen with giant splenic lipoma mimicking liposarcoma: a case report[J]. Int J Surg Case Rep, 2025, 133: 111583. DOI: 10.1016/j.ijscr.2025.111583.
[44]
李朋埕, 仁桑. 脾包虫1例[J]. 西藏医药, 2021, 42(6): 157-158.
[45]
Dudhe S, Nimodia D, Mishra GV, et al. Isolated splenic involvement in hydatid disease: a case report[J]. Radiol Case Rep, 2025, 20(4): 1975-1978. DOI: 10.1016/j.radcr.2025.01.033.
[46]
Samimi A, Rosander AM, Kadell L, et al. An unusual case of echinococcal cyst in the spleen: diagnostic challenges and management strategies[J]. Cureus, 2025, 17(3): e81524. DOI: 10.7759/cureus.81524.
[47]
王永锦, 郭成旺, 刘兴吉, 等. 胃癌合并脾包虫病1例报告并文献复习[J]. 中国普通外科杂志, 2021, 30(10): 1251-1256. DOI: 10.7659/j.issn.1005-6947.2021.10.015.
[48]
Yotsov TI, Dyulgerova S, Draganova D. Laparoscopic splenectomy for solitary splenic hydatid cyst: Case report[J]. J Minimal Access Surg, 2023, 19(2): 317-319. DOI: 10.4103/jmas.jmas_113_22.
[49]
Bergas A, Escrihuela-Vidal F, Fernández Calvo D, et al. Relapsing haemothorax as an unusual presentation of primary angiosarcoma of the spleen[J]. Eur J Case Rep Intern Med, 2020, 7(12): 40. DOI: 10.12890/2020_001944.
[50]
Luo H, Wang T, Xiao L, et al. Multiple disciplinary team management of rare primary splenic malignancy: two case reports[J]. World J Clin Cases, 2022, 10(29): 10535-10542. DOI: 10.12998/wjcc.v10.i29.10535.
[51]
Telvizian T, May AC, Agyei O, et al. Primary splenic angiosarcoma presenting as thrombocytopenia[J]. BMJ Case Rep, 2025, 18(5): e262536. DOI: 10.1136/bcr-2024-262536.
[52]
Awashra A, Sawaftah Z, Odah AB, et al. Spontaneous splenic rupture as a primary manifestation of angiosarcoma: a case report[J]. J Surg Case Rep, 2024, 2024(10): rjae633. DOI: 10.1093/jscr/rjae633.
[53]
Jiang P, Li X, Chen J, et al. Spontaneous splenic rupture as the initial symptom of splenic angiosarcoma: case report and literature review[J]. Front Oncol, 2024, 14: 1366554. DOI: 10.3389/fonc.2024.1366554.
[54]
Juin Hsien BL, Shelat VG. Spleen angiosarcoma: a world review[J]. Expert Rev Gastroenterol Hepatol, 2021, 15(10): 1115-1141. DOI: 10.1080/17474124.2021.1945920.
[55]
Gómez Sánchez J, López-Cantarero García-Cervantes M, Segovia Cornejo E, et al. Primary splenic angiosarcoma: an aggressive and infrequent pathology[J]. Rev Esp Enferm Dig, 2022, 114(2): 761-762. DOI: 10.17235/reed.2022.8976/2022.
[56]
Cao J, Wang J, He C, et al. Angiosarcoma: a review of diagnosis and current treatment[J]. Am J Cancer Res, 2019, 9(11): 2303-2313.
[57]
Lei Y, Huang Q, Li X, et al. Characteristics and survival outcomes of primary splenic cancers: a SEER population-based study[J]. Medicine, 2022, 101(3): e28539. DOI: 10.1097/md.0000000000028539.
[58]
Dirven I, Leclercq P, D'Hondt L, et al. Primary splenic angiosarcoma: a case series of a rare oncological entity and diagnostic challenge[J]. Acta Oncol, 2024, 63: 192-197. DOI: 10.2340/1651-226X.2023.35412.
[59]
Li W. The 5th edition of the World Health Organization classification of hematolymphoid tumors[M]//Leukemia Neoplasms: Exon Publications, 2022: 1-21. DOI: 10.36255/exon-publications-leukemia-who-5th-edition-hematolymphoid-tumors.
[60]
Geyer JT, Ruan J, Kluk MJ, et al. T(14; 22)(q32; q11) translocation involving IGH and IGL acquired at progression of splenic marginal zone lymphoma treated with rituximab, ibrutinib, and obinutuzumab[J]. Ann Hematol, 2025, 104(3): 2005-2011. DOI: 10.1007/s00277-025-06282-5.
[61]
Chen Y, Chen T, Fan S, et al. A rare case of splenic marginal zone lymphoma with MYD88 mutation transformed into diffuse large B-cell lymphoma: case report and literature review[J]. Ann Hematol, 2025, 104(2): 1269-1274. DOI: 10.1007/s00277-024-06080-5.
[62]
李智慧, 李新萍, 王彦丽, 等. 脾边缘区淋巴瘤短期转化为弥漫大B细胞淋巴瘤1例并文献复习[J]. 白血病·淋巴瘤, 2025, 34(2): 111-113. DOI: 10.3760/cma.j.cn115356-20240304-00029.
[63]
Riller Q, Cohen-Aubart F, Roos-Weil D. Lymphomes spléniques: diagnostic et prise en charge[J]. La Rev De Médecine Interne, 2022, 43(10): 608-616. DOI: 10.1016/j.revmed.2022.05.009.
[64]
Iannitto E, Ferrero S, Bommier C, et al. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase Ⅱ study[J]. Haematologica, 2024, 109(7): 2297-2302. DOI: 10.3324/haematol.2023.284109.
[65]
Zamò A, van den Brand M, Climent F, et al. Correction to: The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop[J]. Virchows Arch, 2023, 483(3): 437. DOI: 10.1007/s00428-023-03646-y.
[66]
Hanna M, Trus M, DiMaria E. Splenic diffuse red pulp small B-cell lymphoma with overlapping clinical and immunophenotypic features with hairy cell leukaemia: a case report and a review of the literature[J]. Genes, 2025, 16(4): 467. DOI: 10.3390/genes16040467.
[67]
Mirandari A, Parker H, Ashton-Key M, et al. The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications[J]. Explor Target Anti Tumor Ther, 2024, 5(4): 877-901. DOI: 10.37349/etat.2024.00253.
[68]
Bonfiglio F, Bruscaggin A, Guidetti F, et al. Genetic and phenotypic attributes of splenic marginal zone lymphoma[J]. Blood, 2022, 139(5): 732-747. DOI: 10.1182/blood.2021012386.
[69]
王露, 施晴, 赵维莅, 等. POD24的脾边缘区淋巴瘤的临床特征及预后[J]. 中华血液学杂志, 2025, 46(1): 81-87. DOI: 10.3760/cma.j.cn121090-20240729-00285.
[70]
吕瑞, 阎禹廷, 易树华, 等. POD24在106例伴骨髓侵犯脾边缘区淋巴瘤中的预后意义[J]. 中华血液学杂志, 2020, 41(3): 228-233. DOI: 10.3760/cma.j.issn.0253-2727.2020.03.008.
[71]
Cheah CY, Seymour JF. Marginal zone lymphoma: 2023 update on diagnosis and management[J]. American J Hematol, 2023, 98(10): 1645-1657. DOI: 10.1002/ajh.27058.
[72]
Gulati S, Jeon H, Vijay A. Littoral cell angiomas: Benign lesion with a penchant for visceral malignancies[J]. Ann Hepatobiliary Pancreat Surg, 2023, 27(1): 1-5. DOI: 10.14701/ahbps.22-062.
[73]
Rai M, Gupta N. Littoral Cell Splenic Angioma[M]. StatPearls. Treasure Island (FL): StatPearls Publishing LLC, 2025.
[1] 王子怡, 谢苗苗, 薄舟洋, 孙园园, 武莉娜, 王睿丽. 产后子宫坏死的超声造影表现及诊断价值[J/OL]. 中华医学超声杂志（电子版）, 2026, 23(05): 400-407.
[2] 曾维波, 何燕妮, 熊燃, 王珍, 许智莉, 刘红梅. 两广地区颈动脉狭窄及广东地区肾动脉狭窄与血管超声危急值管理现状调研[J/OL]. 中华医学超声杂志（电子版）, 2026, 23(05): 355-359.
[3] 陈曼, 郑雯, 常才, 俞清, 肖沪生, 赵宝珍, 施仲伟, 陈悦, 李丽蟾, 王文平. 上海市超声诊断设备配置现状调查与质量控制管理策略优化[J/OL]. 中华医学超声杂志（电子版）, 2026, 23(05): 369-373.
[4] 田雨, 罗蓉. 注意缺陷多动障碍功能缺陷评估量表的研究与临床应用现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2026, 22(03): 185-193.
[5] 范祖莉, 谭惠文, 朱慧莉. 《女性雄激素过多症评估临床实践指南》解读：从机制到临床实践[J/OL]. 中华妇幼临床医学杂志(电子版), 2026, 22(03): 204-213.
[6] 何宇杭, 曹中伟. 中性粒细胞百分比-白蛋白比值与乳腺癌的关联性及预测效能研究[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 279-283.
[7] 许颜浩, 邓正根, 张晓坡, 甘卫东, 郭宏骞. 基于CT角度界面和溢啤酒征对乏脂性肾血管平滑肌脂肪瘤与肾透明细胞癌的鉴别[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(03): 273-278.
[8] 李钰, 叶璟威, 戚维天, 叶云林, 李向东, 李志勇, 刘卓炜. 广东省医学会泌尿外科疑难病例多学科会诊（第30期）——严重泌尿系感染伴淋巴结肿大[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(03): 358-362.
[9] 张中喜, 邹加良, 张清池, 刘云钦, 江俊学. 儿童Pantaloon疝四例诊治报道并文献复习[J/OL]. 中华疝和腹壁外科杂志(电子版), 2026, 20(03): 357-360.
[10] 中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南（2026年版）[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(04): 443-507.
[11] 杜飞, 郑希彦, 陈贤清, 李瑞曦, 张广权, 史宪杰. 循环肿瘤DNA在胰腺癌早期诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(03): 433-438.
[12] 马凯蒂, 哈团结. 基于机器学习的糖尿病肾脏病患者疲乏状态诊断预测模型构建[J/OL]. 中华肾病研究电子杂志, 2026, 15(03): 144-150.
[13] 张帅, 朱欣宇, 俞银燕, 郑晓汾, 康玉国. 凝血检验项目在眼底动脉血栓诊断治疗中的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2026, 16(03): 184-188.
[14] 齐洪武, 徐泽雨. 脑脓肿的临床诊治进展[J/OL]. 中华临床医师杂志(电子版), 2026, 20(04): 327-331.
[15] 中国卒中学会遗传学分会. 肯尼迪病诊断和管理中国专家共识2025[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(03): 240-249.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号

AI
小
编
AI小编
你好！我是《中华医学电子期刊资源库》AI小编，有什么可以帮您的吗？